Shares of CervoMed Inc. (NASDAQ:CRVO - Get Free Report) have received an average rating of "Moderate...
CervoMed Inc. (NASDAQ:CRVO - Get Free Report) saw a significant decrease in short interest in May. A...
New hires and promotions in the biopharma industry, including: Biorestorative, Cervomed, Cristcot, D...
D. Boral Capital reiterated a "buy" rating and issued a $10.00 price objective on shares of CervoMed...
Strengthening CMC leadership to prepare for scaled up neflamapimod manufacturing...